Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer
1Cancer Science Institute of Singapore, National University of Singapore, Singapore.
Abstract:
Runt-related transcription factor 3 (RUNX3) is a well-documented tumour suppressor that is frequently inactivated in gastric cancer. Here, we define a novel mechanism by which RUNX3 exerts its tumour suppressor activity involving the TEAD-YAP complex, a potent positive regulator of proliferative genes. We report that the TEAD-YAP complex is not only frequently hyperactivated in liver and breast cancer, but also confers a strong oncogenic activity in gastric epithelial cells. The increased expression of TEAD-YAP in tumour tissues significantly correlates with poorer overall survival of gastric cancer patients. Strikingly, RUNX3 physically interacts with the N-terminal region of TEAD through its Runt domain. This interaction markedly reduces the DNA-binding ability of TEAD that attenuates the downstream signalling of TEAD-YAP complex. Mutation of RUNX3 at Arginine 122 to Cysteine, which was previously identified in gastric cancer, impairs the interaction between RUNX3 and TEAD. Our data reveal that RUNX3 acts as a tumour suppressor by negatively regulating the TEAD-YAP oncogenic complex in gastric carcinogenesis.
Insights
Runt-related transcription factor 3 (RUNX3) suppresses tumors by inhibiting the TEAD-YAP complex, a key driver of cancer cell proliferation. This interaction is crucial for its tumor suppressor function in gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Runt-related transcription factor 3 (RUNX3) is a known tumor suppressor frequently inactivated in gastric cancer.
- The TEAD-YAP complex is a potent regulator of proliferative genes and is hyperactivated in various cancers, including liver and breast cancer.
Purpose of the Study:
- To elucidate a novel mechanism of RUNX3 tumor suppressor activity involving the TEAD-YAP complex in gastric cancer.
- To investigate the role of TEAD-YAP complex hyperactivation in gastric carcinogenesis and its correlation with patient survival.
Main Methods:
- Investigated the physical interaction between RUNX3 and the TEAD-YAP complex using molecular biology techniques.
- Assessed the impact of RUNX3-TEAD interaction on TEAD DNA-binding ability and downstream signaling.
- Analyzed RUNX3 mutations, specifically R122C, for their effect on RUNX3-TEAD interaction.
Main Results:
- The TEAD-YAP complex exhibits strong oncogenic activity in gastric epithelial cells and its increased expression correlates with poorer patient survival.
- RUNX3 directly binds to the N-terminal region of TEAD, reducing its DNA-binding ability and attenuating TEAD-YAP signaling.
- A known gastric cancer mutation (RUNX3 R122C) impairs the interaction between RUNX3 and TEAD.
Conclusions:
- RUNX3 functions as a tumor suppressor in gastric carcinogenesis by negatively regulating the oncogenic TEAD-YAP complex.
- Targeting the RUNX3-TEAD interaction could represent a novel therapeutic strategy for gastric cancer.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...